Trial intelligence / Profile preview

DETECT: MultiHance vs Magnevist in Breast MRI

NCT00486473Phase 3Completed

Sponsor
Bracco Diagnostics Inc.
Start
Jul 2007
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of gadobenate dimeglumine in breast cancer, sponsored by Bracco Diagnostics Inc.. Started Jul 2007; status: completed.

02

Drugs

gadobenate dimeglumine
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00486473.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00486473.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call